Company Description
NutraLife BioSciences, Inc., together with its subsidiaries, engages in the development, manufacture, and distribution of nutraceutical, dietary, wellness, and cannabidiol (CBD) products.
Its CBD products include cannabinoid-rich hemp oil derived from industrial hemp; tinctures; topical lotions and oils applied directly to the skin to treat pain or inflammation; face creams; massage oils; nutraceutical sprays with CBD as an added ingredient; and pet products.
The company also offers other products, such as skincare and sanitizer products. NutraLife BioSciences, Inc. sells its products through nutralifebiosciences.com, as well as through private label distributors, online retailers, and retail outlets.
The company was formerly known as NutraFuels, Inc. and changed its name to NutraLife BioSciences, Inc. in March 2019.
NutraLife BioSciences, Inc. was incorporated in 2010 and is based in Coconut Creek, Florida.
Country | United States |
Founded | 2010 |
Industry | Drug Manufacturers - Specialty & Generic |
Sector | Healthcare |
Employees | 12 |
CEO | Edgar Ward |
Contact Details
Address: 6601 Lyons Road L 6 Coconut Creek, Florida 33073 United States | |
Phone | 888 509 8901 |
Website | nutralifebiosciences.com |
Stock Details
Ticker Symbol | NLBS |
Exchange | OTCMKTS |
Fiscal Year | January - December |
Reporting Currency | USD |
CIK Code | 0001563463 |
CUSIP Number | 67098B107 |
ISIN Number | US67098B1070 |
Employer ID | 46-1482900 |
SIC Code | 2020 |
Key Executives
Name | Position |
---|---|
Edgar Ward | Founder, President, Chief Executive Officer and Director |
Nicholas E Ward | Project and Operations Manager |
Dr. Kenneth L Duchin Ph.D. | Chief Clinical Developer |
Dr. Hongxiang Hui M.D., Ph.D. | Chief Medical Advisor and Member of Advisory Board |
Latest SEC Filings
Date | Type | Title |
---|---|---|
Mar 31, 2023 | NT 10-K | Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 |
Feb 28, 2023 | 8-K | Current Report |
Nov 21, 2022 | 10-Q | Quarterly Report |
Nov 14, 2022 | NT 10-Q | Notification of inability to timely file Form 10-Q or 10-QSB |
Oct 12, 2022 | 8-K | Current Report |
Aug 22, 2022 | 10-Q | Quarterly Report |
Aug 17, 2022 | 8-K | Current Report |
Aug 15, 2022 | NT 10-Q | Notification of inability to timely file Form 10-Q or 10-QSB |
May 23, 2022 | 10-Q | Quarterly Report |
May 16, 2022 | NT 10-Q | Notification of inability to timely file Form 10-Q or 10-QSB |